研究报告 |
|
|
|
|
功能化外泌体重编程免疫细胞与肿瘤细胞之间靶向识别* |
项建1,叶邦策1,尹斌成1,2,**() |
1 华东理工大学生物反应器工程国家重点实验室 上海 200237 2 石河子大学化学化工学院 石河子 832003 |
|
Functionalized Exosomes Reprogram the Targeted Recognition Between Immune Cells and Tumor Cells |
XIANG Jian1,YE Bang-ce1,YIN Bin-cheng1,2,**() |
1 State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, China 2 School of Chemistry and Chemical Engineering, Shihezi University, Shihezi 832003, China |
[1] |
Zhang H M, Chen J B. Current status and future directions of cancer immunotherapy. Journal of Cancer, 2018, 9(10): 1773-1781.
doi: 10.7150/jca.24577
pmid: 29805703
|
[2] |
Hegde P S, Chen D S. Top 10 challenges in cancer immunotherapy. Immunity, 2020, 52(1): 17-35.
doi: S1074-7613(19)30530-8
pmid: 31940268
|
[3] |
Coulie P G, Van den Eynde B J, van der Bruggen P, et al. Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy. Nature Reviews Cancer, 2014, 14(2): 135-146.
doi: 10.1038/nrc3670
pmid: 24457417
|
[4] |
Kim G B, Nam G H, Hong Y, et al. Xenogenization of tumor cells by fusogenic exosomes in tumor microenvironment ignites and propagates antitumor immunity. Science Advances, 2020, 6(27): eaaz2083.
|
[5] |
Sadelain M, Rivière I, Riddell S. Therapeutic T cell engineering. Nature, 2017, 545(7655): 423-431.
doi: 10.1038/nature22395
|
[6] |
Maude S L, Frey N, Shaw P A, et al. Chimeric antigen receptor T cells for sustained remissions in leukemia. The New England Journal of Medicine, 2014, 371(16): 1507-1517.
doi: 10.1056/NEJMoa1407222
pmid: 25317870
|
[7] |
Jackson H J, Rafiq S, Brentjens R J. Driving CAR T-cells forward. Nature Reviews Clinical Oncology, 2016, 13(6): 370-383.
doi: 10.1038/nrclinonc.2016.36
pmid: 27000958
|
[8] |
Bonifant C L, Jackson H J, Brentjens R J, et al. Toxicity and management in CAR T-cell therapy. Molecular Therapy - Oncolytics, 2016, 3: 16011.
doi: 10.1038/mto.2016.11
|
[9] |
Zhang Y, Bi J Y, Huang J Y, et al. Exosome: a review of its classification, isolation techniques, storage, diagnostic and targeted therapy applications. International Journal of Nanomedicine, 2020, 15: 6917-6934.
doi: 10.2147/IJN.S264498
pmid: 33061359
|
[10] |
Gurung S, Perocheau D, Touramanidou L, et al. The exosome journey: from biogenesis to uptake and intracellular signalling. Cell Communication and Signaling, 2021, 19(1): 47.
doi: 10.1186/s12964-021-00730-1
pmid: 33892745
|
[11] |
Xu M, Feng T, Liu B W, et al. Engineered exosomes: desirable target-tracking characteristics for cerebrovascular and neurodegenerative disease therapies. Theranostics, 2021, 11(18): 8926-8944.
doi: 10.7150/thno.62330
pmid: 34522219
|
[12] |
Wang X Y, Huang J, Chen W J, et al. The updated role of exosomal proteins in the diagnosis, prognosis, and treatment of cancer. Experimental & Molecular Medicine, 2022, 54(9): 1390-1400.
|
[13] |
Liang Y J, Duan L, Lu J P, et al. Engineering exosomes for targeted drug delivery. Theranostics, 2021, 11(7): 3183-3195.
doi: 10.7150/thno.52570
pmid: 33537081
|
[14] |
Yan H, Li S, Zhou L F, et al. Selection of DNA aptamers against DC-SIGN protein. Molecular and Cellular Biochemistry, 2007, 306(1-2): 71-77.
pmid: 17660953
|
[15] |
Yang Y, Hong Y, Nam G H, et al. Virus-mimetic fusogenic exosomes for direct delivery of integral membrane proteins to target cell membranes. Advanced Materials, 2017, 29(13): 1605604.
doi: 10.1002/adma.v29.13
|
[16] |
Zhao H, Xu J, Li Y, et al. Nanoscale coordination polymer based nanovaccine for tumor immunotherapy. ACS Nano, 2019, 13(11): 13127-13135.
doi: 10.1021/acsnano.9b05974
pmid: 31710460
|
[17] |
Valadi H, Ekström K, Bossios A, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature Cell Biology, 2007, 9(6): 654-659.
doi: 10.1038/ncb1596
pmid: 17486113
|
[18] |
Cho E, Nam G H, Hong Y, et al. Comparison of exosomes and ferritin protein nanocages for the delivery of membrane protein therapeutics. Journal of Controlled Release, 2018, 279: 326-335.
doi: S0168-3659(18)30221-9
pmid: 29679665
|
[19] |
Koh E, Lee E J, Nam G H, et al. Exosome-SIRPα, a CD47 blockade increases cancer cell phagocytosis. Biomaterials, 2017, 121: 121-129.
doi: S0142-9612(17)30004-2
pmid: 28086180
|
[20] |
Yang Y, Hong Y, Cho E, et al. Extracellular vesicles as a platform for membrane-associated therapeutic protein delivery. Journal of Extracellular Vesicles, 2018, 7(1): 1440131.
doi: 10.1080/20013078.2018.1440131
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|